Abstract: A battery pack includes a secondary battery; and a protection device including: a measurement unit coupled to the secondary battery and configured to measure a temperature and a voltage of the secondary battery; a temperature estimation unit coupled to the measurement unit and configured to estimate a future temperature of the secondary battery; and a charging/discharging unit coupled to the secondary battery and configured to adjust a current or an input voltage applied to the secondary battery based on the future temperature and the voltage of the secondary battery.

Abstract: The invention provides a process for preparing a cell-binding agent chemically coupled to a drug. The process comprises covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent and a subsequent purification step.

Abstract: A self-diagnosis method and apparatus for measuring results from blood analyzers, the method comprising: generating an acquisition transmittance curve according to the changes in transmittance rate of sample during a sample acquisition process; determining whether there is an anomaly in the acquisition process according to the acquisition transmittance rate curve; if there is no anomaly in the acquisition process, determining that the measurement results of the blood sample are credible; and if there is an anomaly in the acquisition process, determining that there is a doubt about the measured results of the blood samples, the self-diagnosis method and apparatus for measuring results from blood analyzer can improve the accuracy of self-diagnosis of measured results from blood analyzers, and reducing the false positive rate, at the same time, the workload of users in examining and verifying the measured results is reduced, thereby saving on measuring costs.

Abstract: The invention provides a process for preparing a cell-binding agent chemically coupled to a drug. The process comprises covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent and a subsequent purification step.

Abstract: The invention provides a nutritional supplement and/or pharmaceutical composition for tableting comprising an embedded lubrication matrix. The embedded lubrication matrix comprises an oily liquid finely dispersed in an oil insoluble material. A method of lubricating a nutritional supplement or pharmaceutical composition for tableting using a matrix with embedded lubrication is also provided.

Abstract: The present application discloses a method and device of detecting fatigue driving, comprising: analyzing an eye image in the driver's eye image area with a rectangular feature template to obtain the upper eyelid line; determining the eye closure state according to the curvature or curvature feature value of the upper eyelid line; and collecting statistics on the eye closure state and thereby determining whether the driver is in a fatigue state. The present application determines whether the eyes are opened or closed according to the shape of the upper eyelid, which is more accurate because the upper eyelid line has characteristics of higher relative contrast, anti-interference capacity, and adaptability to the changes in the facial expression.

Abstract: A cable having a current leakage detection function includes three current-carrying core wires. Each current-carrying core wire is wrapped by an insulating layer, so that the current-carrying core wires are electrically insulated from one another. The insulating layer of at least one of the current-carrying core wires is wrapped by a metal wire net. Current guiding wires in contact with the metal wire net or a single-sided conductive film laminated outside the metal wire net is utilized to achieve the effect of timely and effectively conducting a leakage current to a leakage current detection device, so as to improve the reliability of leakage current detection.

Abstract: A high sensitivity leakage current detection interrupter (LCDI) includes a shielded wire, a current leakage detection unit, and a tripping mechanism. A live core and a neutral core of the shielded wire are respectively wrapped in two conductive shell wires. The current leakage detection unit includes a pair of rectifying diodes reversely connected in series between a live line and a neutral line of a power supply, a voltage dropping resistor, thyristors, and resistor-capacitor (RC) voltage dropping filter circuits. The tripping mechanism includes control units with on/off respectively controlled by the thyristors. When either of the thyristors is turned on, the corresponding control unit is turned on, and the tripping mechanism is actuated to switch off the power supply.

Abstract: A battery pack includes a secondary battery; and a protection device including: a measurement unit coupled to the secondary battery and configured to measure a temperature and a voltage of the secondary battery; a temperature estimation unit coupled to the measurement unit and configured to estimate a future temperature of the secondary battery; and a charging/discharging unit coupled to the secondary battery and configured to adjust a current or an input voltage applied to the secondary battery based on the future temperature and the voltage of the secondary battery.

Abstract: The invention provides a process for preparing a cell-binding agent chemically coupled to a drug. The process comprises covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent and a subsequent purification step.

Abstract: The invention provides a process for preparing a cell-binding agent chemically coupled to a drug. The process comprises covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent and a subsequent purification step.

Abstract: The invention relates generally to a new functional protein S assay and kit that is based on the ability of endogenous protein S to prolong clotting time. In the assay procedure, a test plasma sample is diluted with protein S deficient plasma, followed by the addition of purified or recombinant tissue factor (pTF or rTF), purified natural or synthetic phospholipid (pPL or sPL) and activated protein C (APC) or protein C activator (PCA). The clotting time is then measured and compared to a standard curve or a normal control.

Abstract: A sectional floor mat system of floor mats and edging sections or pieces that are removably engaged with the floor mats. The floor mat system includes at least one mat and sufficient edging to border at least one of the side edges of the at least one mat. In many embodiments, there is sufficient edging to border all side edges of the at least one mat, when multiple mats, if present, and connected together. The edging pieces of the invention, and other variations thereof, when combined with mats, provide a floor covering system that is easy for the user to set-up, disassemble as needed, and inhibit tripping on the edges of mats.

Abstract: The present application discloses a method and device of detecting fatigue driving, comprising: analyzing an eye image in the driver's eye image area with a rectangular feature template to obtain the upper eyelid line; determining the eye closure state according to the curvature or curvature feature value of the upper eyelid line; and collecting statistics on the eye closure state and thereby determining whether the driver is in a fatigue state. The present application determines whether the eyes are opened or closed according to the shape of the upper eyelid, which is more accurate because the upper eyelid line has characteristics of higher relative contrast, anti-interference capacity, and adaptability to the changes in the facial expression.

Abstract: A leakage current detection interrupter with fire protection means comprising: (i) a movable assembly housing; (ii) two fixed contact holders each having a fixed contact point; (iii)) two movable contact holders each having a fixed end and a movable end with a movable contact point; (iv) a movable assembly that moves between a first position and a second position; (v) a resetting component; (vi) a resetting component spring; (vii) an electromagnetic tripping component, which, when energized, which is responsive to a fault condition, causes the movable assembly to be in the second position from the first position; (viii) an leakage current protection circuit assembled on a printed circuit board for detecting the fault condition; and (ix) a set of three electrical wires: a first wire, a second wire, and a third wire to an appliance, wherein the first wire and the second wire are protected by a plurality of protective shields.

Abstract: A high sensitivity leakage current detection interrupter (LCDI) includes a shielded wire, a current leakage detection unit, and a tripping mechanism. A live core and a neutral core of the shielded wire are respectively wrapped in two conductive shell wires. The current leakage detection unit includes a pair of rectifying diodes reversely connected in series between a live line and a neutral line of a power supply, a voltage dropping resistor, thyristors, and resistor-capacitor (RC) voltage dropping filter circuits. The tripping mechanism includes control units with on/off respectively controlled by the thyristors. When either of the thyristors is turned on, the corresponding control unit is turned on, and the tripping mechanism is actuated to switch off the power supply.

Abstract: The invention provides processes for preparing a cell-binding agent chemically coupled to a drug. A first process comprises covalently attaching a linker to a cell-binding agent, an optional purification step, conjugating a drug to the cell-binding agent, a subsequent purification step, and optional holding steps. A second process comprises covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent, a subsequent purification step, holding steps, and optionally a tangential flow filtration (TFF) step.

Abstract: A cable having a current leakage detection function includes three current-carrying core wires. Each current-carrying core wire is wrapped by an insulating layer, so that the current-carrying core wires are electrically insulated from one another. The insulating layer of at least one of the current-carrying core wires is wrapped by a metal wire net. Current guiding wires in contact with the metal wire net or a single-sided conductive film laminated outside the metal wire net is utilized to achieve the effect of timely and effectively conducting a leakage current to a leakage current detection device, so as to improve the reliability of leakage current detection.

Abstract: A leakage current detection interrupter with fire protection means, comprising: (i) a leakage current protection circuit, (ii) an electrical cord with metallic fire shields, and (iii) a fire protection circuit, wherein, in operation, the leakage current protection circuit and the fire protection circuit detect a fault condition including a leakage current, a ground fault and a fire hazard, and disconnect the source of electricity from the at least one user accessible load when leakage current, ground fault or fire hazard is detected. The electrical cord with metallic fire shields, the fire protection circuit, and the indicator circuit can be combined with any ground fault circuit interrupter, arc fault circuit interrupter, immerse detection circuit interrupter, appliance leakage current interrupter and electronic leakage current interrupter.

Abstract: The invention provides a process for preparing a cell-binding agent chemically coupled to a drug. The process comprises covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent and a subsequent purification step.